BridgeMD
Tests treatment safety and results for NK/T-cell Lymphoma
Official title PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
ClinicalTrials.gov ID: NCT05662540
What this study is testing
- What it's testing
- This study intends to evaluate the application value of Positron Emission Tomography/Magnetic Resonance (PET/MR) in the staging and efficacy evaluation of NK/T cell lymphoma, aiming to explore a more accurate system for predicting the prognosis of patients and guiding the treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 70
You may be able to join if
- Pathologically diagnosed NK/T-cell lymphoma based on the WHO classification 2016
- Age from 14 to 70 years-old
- ECOG 0-2 score
- Patients with a life expectancy of at least 6 months
- Patient has not been treated before for NK/T cell lymphoma
You likely can't join if
- \- people who meet any of the following criteria are not eligible for study entry
- Diagnosed aggressive NK cell leukemia
- Pregnant or lactating women
- Liver and kidney insufficiency
- Other PET/MR contraindications:
- Those with implanted functional electronic devices such as cardiac pacemakers
See the full eligibility criteria
- Pathologically diagnosed NK/T-cell lymphoma based on the WHO classification 2016
- Age from 14 to 70 years-old
- ECOG 0-2 score
- Patients with a life expectancy of at least 6 months
- Patient has not been treated before for NK/T cell lymphoma
- Commit to abide by the research procedures and cooperate with the implementation of the whole process of research
- Written informed consent
- \- people who meet any of the following criteria are not eligible for study entry
- Diagnosed aggressive NK cell leukemia
- Pregnant or lactating women
- Liver and kidney insufficiency
- Other PET/MR contraindications:
- Those with implanted functional electronic devices such as cardiac pacemakers
- Carotid aneurysm clipping and other implants are ferromagnetic materials
- Implanted perfusion devices such as insulin perfusion pumps
- Those who do not cooperate in examinations such as coma, mental illness, and critically ill patients
- Those who are claustrophobic
- Other concurrent and uncontrolled medical conditions that the investigator believes will affect the patient's participation in the study
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.